Endocrine Testing Market Share, Trends And Growth By 2034

Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence

What Is the Forecasted Market Size of the Endocrine Testing Market by 2029?
The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.79 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to " $3.89 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

What Are the Major Drivers Propelling the Growth of the Endocrine Testing Market?
The rising prevalence of diabetes is expected to propel the growth of the endocrine testing market going forward. Diabetes refers to a group of diseases that result in high blood sugar (glucose) levels. The prevalence of diabetes is increasing due to factors such as unhealthy diets, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine testing, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, is used in diabetes to diagnose the condition, monitor glucose levels, and assess insulin production and sensitivity. For instance, in June 2024, according to the National Health Service (NHS), UK-based government department, among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend in this age group. The data reflects a rapid escalation in diabetes prevalence among younger populations. Therefore, the rising prevalence of diabetes is driving the endocrine testing market.

How Is the Endocrine Testing Market Structured Across Its Key Segment Categories?
The endocrine testingmarket covered in this report is segmented –

1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users

Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test

What Are the Current Trends Influencing the Endocrine Testing Market?
Major companies operating in the endocrine testing market are developing point-of-care testing solutions to enhance the accessibility and efficiency of diagnosing endocrine disorders. Point-of-care testing allows for quick results, which can aid in the rapid diagnosis and management of heart failure in patients presenting with symptoms such as shortness of breath and fatigue. For instance, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, launched a point-of-care NT-proBNP test in India, specifically designed for screening diabetes patients at risk of cardiovascular diseases, such as heart failure (HF). It facilitates early detection and intervention, enabling clinicians to identify high-risk T2D patients and initiate timely treatment discussions. The test facilitates early detection and intervention, allowing the clinicians to identify high-risk T2D patients and initiate timely treatment discussions, ultimately fostering improved outcomes and patient well-being.

Which Companies Are Recognized as Major Innovators in the Endocrine Testing Market?
Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Get the detailed endocrine testing market report today
https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

Which Regional Markets Are Likely to See the Most Significant Expansion in the Coming Years?
North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company